Skip to main content
. 2021 Sep 29;10(21):7503–7513. doi: 10.1002/cam4.4268

FIGURE 1.

FIGURE 1

Flow chart of all the patients. AI, angiogenesis inhibitor; EGFR, epidermal growth factor receptor; NSCLC, non‐small cell lung cancer; TKI, tyrosine kinase inhibitor